Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Cesamet(R) (Nabilone) for the Prevention of Postoperative Nausea and Vomiting in Elective Surgery

NCT02115529 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02115529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Cesamet(R) (Nabilone) for the Prevention of Postoperative Nausea and Vomiting in Elective Surgery
Lead sponsor
Unity Health Toronto
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
November 30, 2015
Enrollment
331 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea and vomiting